Skip to main content
Premium Trial:

Request an Annual Quote

BioMerieux, Proteome Sciences, Mitsubishi Pharma, Ludesi, GenoLogics, GeneBio, University of Dundee, PerkinElmer, Becton Dickinson


BioMerieux Will Use Proteome Sciences' Biomarkers to Develop Stroke Dx

Proteome Sciences this week said it has penned a license agreement with BioMerieux to use its biomarkers in blood to detect, diagnose, and monitor stroke.

Under the terms of the agreement, BioMerieux will test Proteome Sciences' biomarkers for a stroke diagnostic panel across a patient population in Continental Europe.

The biomarkers were discovered and validated using a combination of different proteomic approaches, all of which are available for external use through Proteome Sciences' ProteoShop platform.

Financial terms were not disclosed.

Mitsubishi Pharma Contracts Ludesi for 2D Gel Image Analysis

Mitsubishi Pharma has selected Ludesi AB for its image analysis-processing of 2D gels, the Swedish company said this week.

Ludesi offers 2D gel image analysis as a service through web-based software that can be accessed by scientists from anywhere in the world.

Financial details were not disclosed.

GenoLogics, GeneBio to Integrate Technologies to Help Analyze Proteomic Data

GenoLogics Life Sciences Software and Geneva Bioinformatics will integrate Phenyx and Proteus to develop a product for managing and analyzing proteomics data, the companies said this week.

GeneBio's Phenyx, a proteomics MS data-analysis platform, identifies and characterizes proteins and peptides from mass spectrometry data. GenoLogics' Proteus is software for lab and data-management.

Under the terms of the agreement, Phenyx will be able to integrate data with Proteus, which will enable users to optimize their ability to search and identify proteins from a centralized data-management platform and user interface.

Financial details were not disclosed.

University of Dundee's Proteomics Facility to Use GenoLogics' Proteus Software

The proteomics facility in Scotland's University of Dundee will use GenoLogics' Proteus software for laboratory information and scientific data management, the company said last week.

The university's FingerPrints Proteomics Facility provides mass spectrometry resources to academic and industrial researchers.

The facility said it will use the software to "improve the services we offer to our ... internal and external customers in the UK and beyond."

FingerPrints is "particularly interested" in using the Proteus to offer new services, including phosphorylation site mapping.

PerkinElmer to Pay Shareholders $.07 Per-Share Dividend in August

PerkinElmer's board of directors last week declared a regular quarterly dividend of $.07 per share of common stock payable on Aug. 11 to all shareholders of record on July 21, the company said yesterday in a statement.

Becton Dickinson Declares $.22 Quarterly Dividend

Becton Dickinson's board of directors declared a quarterly dividend of $0.215 per common share, the company said this week.

The dividend will be payable on June 30 to holders of record on June 9. The indicated annual dividend rate is $0.86 per share.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.